Where is the Crisis? Six Months After FDA, HHS Announced Plans to Schedule 7-OH, Death Toll Remains at Zero

Where is the Crisis? Six Months After FDA, HHS Announced Plans to Schedule 7-OH, Death Toll Remains at Zero

Source: HART 

Excerpt:

Federal Officials Push Ban While Ignoring Science and Consumer Voices 

Washington, DC — Six months after the U.S. Department of Health and Human Services (HHS)  and the Food and Drug Administration (FDA) announced their intent to schedule 7- hydroxymitragynine (7-OH), a naturally occurring alkaloid derived from kratom, the number  of confirmed deaths linked exclusively to 7-OH still remains zero. 

Despite repeated claims suggesting imminent danger, no data has ever been presented to show  that 7-OH poses any public health threat warranting emergency scheduling. Instead, the  agencies’ actions appear to disregard the lived experiences of thousands of Americans who use  7-OH responsibly to manage pain, improve focus, and support overall well-being. 

Jeff Smith, PhD, national policy director of the Holistic Alternative Recovery Trust  (HART), issued the following statement: 

“What facts drove the recommendation from HHS? None. No evidence was presented in August  or over the past 6 months. Not a single independent study. Not one data point specific to 7-OH. 

“If 7-OH posed the kind of urgent danger that would justify emergency action, evidence would  have been presented. It was not. When a reporter asked if the government could attribute even a  single death to 7-OH, no official was able to do so. 

“While stating that doctors don’t know what 7-OH is or how to check for it, HHS also claimed  there is an epidemic of people dying from it. Where is the data showing this? 

“Let’s be clear: 7-OH is not a public health crisis. According to the Food and Drug  Administration’s (FDA) own Adverse Event Reporting System (FAERS), there have been under  75 adverse events ever reported, despite well over a billion doses consumed nationwide.” 

The real public-health danger is coming from unregulated products like Feel Free, which  combines kratom and kava into an addictive cocktail that has caused severe physical and  emotional harm to consumers, including intense withdrawal, depression, skin deterioration, and  emotional instability. 

The FDA abandoned its case against Feel Free but continues to pursue 7-OH, despite no FDA reported deaths, fueling concerns that politics and powerful relationships, including ties to  Robert F. Kennedy Jr., are outweighing real consumer protection. 

“The fixation on 7-OH is a deliberate distraction from these far more dangerous products  flooding the market, many of them marketed without clear warnings and readily available in  convenience stores,” Smith said. “Instead of pursuing a misguided ban, regulators should focus  on consumer protection through consistent, science-based standards applied equally across all  kratom products.”

Smith added that HART continues to call for evidence-based policymaking and open scientific  review before any action is taken that could harm consumers, researchers, and small businesses  operating within the legal botanical products industry. 

“The American people deserve transparency, scientific integrity, and consumer choice,” Smith  said. “The scheduling of 7-OH is a dangerous precedent. It tells consumers their health takes a  back seat to corporate lobbying. It tells researchers their work will be evaluated in the  policymaking sphere based on politics, not evidence. And it tells patients seeking safer  alternatives that Washington would rather push them into the shadows than allow regulated, legal  access.” 

About the Holistic Alternative Recovery Trust (HART) 

The Holistic Alternative Recovery Trust (HART) is a nonprofit policy organization dedicated  to advancing safe, evidence-based access to natural alternatives for recovery and wellness.  HART advocates for scientific transparency, consumer safety, and regulatory accountability in  emerging health and wellness industries.

Where is the Crisis? Six Months After FDA, HHS Announced Plans to Schedule 7-OH, Death Toll Remains at Zero
Facebook
Twitter
LinkedIn
WhatsApp
Email
Print
Scroll to Top